+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

GlaxoSmithKline Plc - Strategy, SWOT and Corporate Finance Report

1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 2
GlaxoSmithKline Plc - Strategy, SWOT and Corporate Finance Report

Summary

GlaxoSmithKline Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360° view of the company.

Key Highlights

GlaxoSmithKline plc (GSK or 'the company') is a healthcare company that develops, manufactures and sells vaccines, pharmaceuticals, over-the-counter (OTC) medicines and consumer healthcare products. The company offers medicines for various therapeutic areas, including respiratory, HIV, metabolic, anti-virals, urogenital, central nervous system, immuno-inflammation, cardiovascular, anti-bacterials and dermatology. GSK markets its products under Volibris, Benlysta SCbelimumab, Benlysta, Augmentin, FluLaval, Bexsero, Menveo, Zovirax, Pronamel, Otrivin, Theraflu, Aquafresh, Abreva and Poligrip brand names. The company merchandises and sells these products through pharmacies, hospitals, wholesalers, and physicians worldwide. It has business presence across the UK, the US and Europe. The company is headquartered in Brentford, Middlesex, the UK.

Scope
  • Detailed information on GlaxoSmithKline Plc required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting GlaxoSmithKline Plc in the form of a SWOT analysis
  • An in-depth view of the business model of GlaxoSmithKline Plc including a breakdown and examination of key business segments
  • Intelligence on GlaxoSmithKline Plc's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
  • News about GlaxoSmithKline Plc, such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
  • Gain understanding of GlaxoSmithKline Plc and the factors that influence its strategies.
  • Track strategic initiatives of the company and latest corporate news and actions.
  • Assess GlaxoSmithKline Plc as a prospective partner, vendor or supplier.
  • Support sales activities by understanding your customers' businesses better.
  • Stay up to date on GlaxoSmithKline Plc's business structure, strategy and prospects.
Note: Product cover images may vary from those shown
2 of 2
Company Snapshot
  • GlaxoSmithKline Plc: Company Overview
  • GlaxoSmithKline Plc: Overview and Key Facts
  • GlaxoSmithKline Plc: Overview
  • GlaxoSmithKline Plc: Key Facts
  • GlaxoSmithKline Plc: Key Employees
  • GlaxoSmithKline Plc: Key Employee Biographies
  • GlaxoSmithKline Plc: Major Products and Services
  • GlaxoSmithKline Plc: Company History
  • GlaxoSmithKline Plc: Management Statement
  • GlaxoSmithKline Plc: Locations and Subsidiaries
  • GlaxoSmithKline Plc: Key Competitors
  • GlaxoSmithKline Plc: Company Analysis
  • GlaxoSmithKline Plc: Business Description
  • GlaxoSmithKline Plc: SWOT Analysis
  • GlaxoSmithKline Plc: SWOT Overview
  • GlaxoSmithKline Plc: Strengths
  • GlaxoSmithKline Plc: Weaknesses
  • GlaxoSmithKline Plc: Opportunities
  • GlaxoSmithKline Plc: Threats
  • GlaxoSmithKline Plc: Corporate Financial Deals Activity
  • GlaxoSmithKline Plc: Financial Deals Overview
  • GlaxoSmithKline Plc: Targets and Partners
  • GlaxoSmithKline Plc: Top Deals 2015 - 2019YTD*
  • GlaxoSmithKline Plc: Advisors
  • GlaxoSmithKline Plc: Top Legal Advisors
  • GlaxoSmithKline Plc: Top Financial Advisors
  • GlaxoSmithKline Plc: Mergers and Acquisitions
  • GlaxoSmithKline Plc: Corporate Venturing
  • GlaxoSmithKline Plc: Capital Raising
  • GlaxoSmithKline Plc: Partnership
  • GlaxoSmithKline Plc: Divestments
  • GlaxoSmithKline Plc: Recent Developments
  • GlaxoSmithKline Plc: News and Events Summary
  • GlaxoSmithKline Plc: Business Expansion
  • GlaxoSmithKline Plc: Contracts
  • GlaxoSmithKline Plc: Corporate Governance
  • GlaxoSmithKline Plc: Financial Deals
  • GlaxoSmithKline Plc: Market Developments
  • GlaxoSmithKline Plc: Red Flags/DistressSignals
  • GlaxoSmithKline Plc: Regulatory and Legal Events
  • GlaxoSmithKline Plc: Research & Development
  • GlaxoSmithKline Plc: Strategy and Operations
Appendix
  • Contact Us
  • Methodology
  • About the Author
List Of Tables
Table 1: GlaxoSmithKline Plc: Key Facts
Table 2: GlaxoSmithKline Plc: Key Employees
Table 3: GlaxoSmithKline Plc: Company History
Table 4: GlaxoSmithKline Plc: Locations and Subsidiaries
Table 5: GlaxoSmithKline Plc: Key Competitors
Table 6: GlaxoSmithKline Plc: Deal Activity by Deal Type - Volume (TTM*)
Table 7: GlaxoSmithKline Plc: M&A Activity by Geography (TTM*)
Table 8: GlaxoSmithKline Plc: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 9: GlaxoSmithKline Plc: M&A Average Deal Size - Value (US$m)
Table 10: GlaxoSmithKline Plc: Targets and Partners
Table 11: GlaxoSmithKline Plc: Top Deals 2015 - 2019YTD*
Table 12: GlaxoSmithKline Plc: Legal Advisor Ranking by Value (US$m)
Table 13: GlaxoSmithKline Plc: Financial Advisor Ranking by Value (US$m)
Table 14: GlaxoSmithKline Plc: M&A Volume and Value Trend (2015 - YTD*2019)
Table 15: GlaxoSmithKline Plc: M&A Activity by Geography (2015 - YTD*2019)
Table 16: GlaxoSmithKline Plc: Corporate Venturing Volume and Value Trend (2015 - YTD*2019)
Table 17: GlaxoSmithKline Plc: Corporate Venturing by Geography (2015 - YTD*2019)
Table 18: GlaxoSmithKline Plc: Capital Raising Volume and Value Trend (2015 - YTD*2019)
Table 19: GlaxoSmithKline Plc: Capital Raising by Deal Type (2015 - YTD*2019)
Table 20: GlaxoSmithKline Plc: Partnership Volume and Value Trend (2015 - YTD*2019)
Table 21: GlaxoSmithKline Plc: Partnership Trend by Deal Type (2015 - YTD*2019)
Table 22: GlaxoSmithKline Plc: Divestments Volume and Value Trend (2015 - YTD*2019)
Table 23: GlaxoSmithKline Plc: Divestments by Geography (2015 - YTD*2019)
Table 24: GlaxoSmithKline Plc: News and Events Summary
Table 25: GlaxoSmithKline Plc: Business Expansion
Table 26: GlaxoSmithKline Plc: Contracts
Table 27: GlaxoSmithKline Plc: Corporate Governance
Table 28: GlaxoSmithKline Plc: Financial Deals
Table 29: GlaxoSmithKline Plc: Market Developments
Table 30: GlaxoSmithKline Plc: Red Flags/DistressSignals
Table 31: GlaxoSmithKline Plc: Regulatory and Legal Events
Table 32: GlaxoSmithKline Plc: Research & Development
Table 33: GlaxoSmithKline Plc: Strategy and Operations

List of Figures
Figure 1: GlaxoSmithKline Plc: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: GlaxoSmithKline Plc: M&A Activity by Geography (TTM*)
Figure 3: GlaxoSmithKline Plc: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Figure 4: GlaxoSmithKline Plc: M&A Average Deal Size - Value (US$m)
Figure 5: GlaxoSmithKline Plc: M&A Volume and Value Trend (2015 - YTD*2019)
Figure 6: GlaxoSmithKline Plc: M&A Activity by Geography (2015 - YTD*2019)
Figure 7: GlaxoSmithKline Plc: Corporate Venturing Volume and Value Trend (2015 - YTD*2019)
Figure 8: GlaxoSmithKline Plc: Corporate Venturing by Geography (2015 - YTD*2019)
Figure 9: GlaxoSmithKline Plc: Capital Raising Volume and Value Trend (2015 - YTD*2019)
Figure 10: GlaxoSmithKline Plc: Capital Raising by Deal Type (2015 - YTD*2019)
Figure 11: GlaxoSmithKline Plc: Partnership Volume and Value Trend (2015 - YTD*2019)
Figure 12: GlaxoSmithKline Plc: Partnership Trend by Deal Type (2015 - YTD*2019)
Figure 13: GlaxoSmithKline Plc: Divestments Volume and Value Trend (2015 - YTD*2019)
Figure 14: GlaxoSmithKline Plc: Divestments by Geography (2015 - YTD*2019)
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll